Online Inquiry
Cat.#: ACPP-1326
| Despition | Galectin 3 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1444 | Human VAMP2 Protein (AC1444) | 5 µg | inquiry |
| ACPP-1397 | Human RNLS Protein (AC1397) | 5 µg | inquiry |
| ACPP-1543 | Human AKR1C3 Protein (AC1543) | 5 µg | inquiry |
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg | inquiry |
| ACPP-1655 | Human RAB23 Protein (AC1655) | 5 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1808 | Human LIF Protein, Yeast (AC1808) | 5 µg | inquiry |
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1721 | Human QPRT Protein (AC1721) | 5 µg | inquiry |
| ACPP-1188 | GRIK1 Blocking Peptide (AC1188) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.